Holen Sie sich die Stockscreener-App
1.31
0.00%
0.00
Humacyte Inc Aktie (HUMA) Neueste Nachrichten
Is Humacyte Inc a good long term investmentStraddle and Strangle Trades & Explosive Capital Growth Plans - earlytimes.in
Humacyte Stock (HUMA) Opinions on FDA Approval for Symvess Product - Quiver Quantitative
Humacyte (HUMA): Benchmark Remains Bullish on Stock - Finviz
Humacyte (HUMA): Benchmark remains bullish on stock - MSN
Humacyte prices 28.4M shares at $2.11 in registered direct offering - MSN
Market Moves: Can Humacyte Inc stock weather global recessionPortfolio Risk Report & Reliable Intraday Trade Plans - moha.gov.vn
Bond Watch: Will Humacyte Inc Equity Warrant stock pay special dividendsJuly 2025 Volume & Low Volatility Stock Recommendations - BỘ NỘI VỤ
Book value per share of Humacyte, Inc. Warrant 2021-27.08.26 on Humacyte – NASDAQ:HUMAW - TradingView
Wall Street analysts see Humacyte, Inc. (HUMA) as a buy: Should you invest? - MSN
Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest? - Finviz
How Humacyte Inc. Equity Warrant stock reacts to global recession fearsBuy Signal & High Accuracy Buy Signal Tips - Newser
Can Humacyte Inc. stock continue upward trendPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Humacyte, Inc. (NASDAQ:HUMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey
Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates - MSN
Humacyte, Inc.'s (NASDAQ:HUMA) largest shareholders are retail investors with 57% ownership, institutions own 26% - Yahoo Finance
Will Humacyte Inc. stock maintain growth storyForecast Cut & High Accuracy Trade Alerts - Newser
Can Humacyte Inc. stock maintain growth trajectoryMarket Volume Summary & Fast Moving Stock Trade Plans - BỘ NỘI VỤ
Humacyte (HUMA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Humacyte stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
What drives Humacyte Inc stock priceGap Up/Gap Down Analysis & Collaborate and Win Together - earlytimes.in
Humacyte, Inc. (NASDAQ:HUMA) Q4 2024 Earnings Call Transcript - MSN
Humacyte (HUMA) Q3 2025 Earnings Call Transcript - The Globe and Mail
Humacyte Ends Sale Agreement with Jefferies LLC - TipRanks
HumacyteOn Nov 21, co delivered notice to Jefferies terminating open market sale agreement entered on Sept 1, 2022 - MarketScreener
Aug Closing: What catalysts could drive Humacyte Inc. stock higherJuly 2025 Analyst Calls & Consistent Profit Alerts - BỘ NỘI VỤ
Aug Wrap: Can Humacyte Inc. stock maintain growth trajectory2025 Retail Activity & Growth Oriented Trading Recommendations - moha.gov.vn
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish - MSN
Humacyte’s Major Breakthroughs Impress Investors: Market Reactions - StocksToTrade
Stock Traders Purchase Large Volume of Humacyte Put Options (NASDAQ:HUMA) - MarketBeat
Humacyte Inc. (HUMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
D. Boral Capital Maintains Humacyte (HUMA) Buy Recommendation - MSN
D. Boral Capital Reiterates "Buy" Rating for Humacyte (NASDAQ:HUMA) - MarketBeat
Humacyte, Inc. (HUMA) stock price, news, quote and history - Yahoo Finance UK
Quantitative breakdown of Humacyte Inc. recent moveMarket Movers & Long-Term Growth Plans - newser.com
Humacyte releases press info on VEITH symposium presentation - Traders Union
D. Boral Capital Reiterates "Buy" Rating for Humacyte (HUMA) | H - GuruFocus
Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results - The Manila Times
Humacyte (Nasdaq: HUMA) Details ATEV Recellularization and 2-Year Trauma Data - Stock Titan
What recovery options are there for Humacyte Inc. Equity WarrantWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Real time pattern detection on Humacyte Inc. stockPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Will Humacyte Inc. Equity Warrant stock see insider buyingDividend Hike & Real-Time Stock Movement Alerts - newser.com
Will Humacyte Inc. see short term momentumJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Will Humacyte Inc. stock deliver shareholder valueJuly 2025 Summary & Risk Controlled Daily Plans - newser.com
Is Humacyte Inc. stock supported by strong cash flows2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
How to interpret RSI for Humacyte Inc. stock2025 Valuation Update & Precise Buy Zone Identification - newser.com
Multi asset correlation models including Humacyte Inc. Equity WarrantWeekly Trade Review & Verified Short-Term Plans - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakoutInsider Selling & Real-Time Price Movement Reports - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for retirement portfolios - newser.com
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFsQuarterly Trade Review & Daily Risk Controlled Trade Plans - newser.com
Will Humacyte Inc. stock benefit from infrastructure spendingEarnings Risk Summary & High Accuracy Trade Signal Alerts - newser.com
Using RSI to spot recovery in Humacyte Inc. Equity Warrant2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
Humacyte Inc: Is It a Time of Strategic Shift? - StocksToTrade
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):